Lahoutte T - Search Results

1

Vaneycken I, D'huyvetter M, Hernot S, De Vos J, Xavier C, Devoogdt N, Caveliers V, Lahoutte T. Vaneycken I, et al. Among authors: lahoutte t. Curr Opin Biotechnol. 2011 Dec;22(6):877-81. doi: 10.1016/j.copbio.2011.06.009. Epub 2011 Jul 2. Curr Opin Biotechnol. 2011. PMID: 21726996 Review.

2

In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport.

Lahoutte T, Caveliers V, Dierickx L, Vekeman M, Everaert H, Mertens J, Bossuyt A. Lahoutte T, et al. Nucl Med Biol. 2001 Feb;28(2):129-34. doi: 10.1016/s0969-8051(00)00184-0. Nucl Med Biol. 2001. PMID: 11295423

3

Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.

Dierickx LO, Lahoutte T, Deron P, Caveliers V, Vanhove C, Everaert H, Bossuyt A. Dierickx LO, et al. Among authors: lahoutte t. Eur J Nucl Med. 2001 Mar;28(3):282-7. doi: 10.1007/s002590000439. Eur J Nucl Med. 2001. PMID: 11315594 Clinical Trial.

4

Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.

Lahoutte T, Caveliers V, Franken PR, Bossuyt A, Mertens J, Everaert H. Lahoutte T, et al. J Nucl Med. 2002 Sep;43(9):1201-6. J Nucl Med. 2002. PMID: 12215559 Free article.

5

Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results.

Caveliers V, Everaert H, John CS, Lahoutte T, Bossuyt A. Caveliers V, et al. Among authors: lahoutte t. J Nucl Med. 2002 Dec;43(12):1647-9. J Nucl Med. 2002. PMID: 12468514 Free article.

6

Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.

Lahoutte T, Mertens J, Caveliers V, Franken PR, Everaert H, Bossuyt A. Lahoutte T, et al. J Nucl Med. 2003 Sep;44(9):1489-94. J Nucl Med. 2003. PMID: 12960197 Free article.

7

Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.

Everaert H, Vanhove C, Lahoutte T, Muylle K, Caveliers V, Bossuyt A, Franken PR. Everaert H, et al. Among authors: lahoutte t. Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1615-9. doi: 10.1007/s00259-003-1317-8. Epub 2003 Sep 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 14504831

8

SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation.

Lahoutte T, Caveliers V, Camargo SM, Franca R, Ramadan T, Veljkovic E, Mertens J, Bossuyt A, Verrey F. Lahoutte T, et al. J Nucl Med. 2004 Sep;45(9):1591-6. J Nucl Med. 2004. PMID: 15347729 Free article.

9

123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients.

Keyaerts M, Lahoutte T, Neyns B, Caveliers V, Vanhove C, Everaert H, Kersemans K, Franken PR, Mertens J, Bossuyt A. Keyaerts M, et al. Among authors: lahoutte t. Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):994-1002. doi: 10.1007/s00259-006-0303-3. Epub 2007 Jan 20. Eur J Nucl Med Mol Imaging. 2007. PMID: 17237962

10

In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology.

Droogmans S, Franken PR, Garbar C, Weytjens C, Cosyns B, Lahoutte T, Caveliers V, Pipeleers-Marichal M, Bossuyt A, Schoors D, Van Camp G. Droogmans S, et al. Among authors: lahoutte t. Eur Heart J. 2007 Sep;28(17):2156-62. doi: 10.1093/eurheartj/ehm263. Epub 2007 Jul 18. Eur Heart J. 2007. PMID: 17636306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page